Estimates Revisions Medpace Holdings, Inc.
Stocks
MEDP
US58506Q1094
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 591.29 USD | -0.35% |
|
-1.56% | +5.28% |
| 09-01 | Medpace Holdings Insider Sold Shares Worth $403,176, According to a Recent SEC Filing | MT |
| 08-29 | Medpace Holdings Insider Sold Shares Worth $2,383,511, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- MEDP Stock
- Consensus Medpace Holdings, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
